A Clinical trial to study the effects of Homoeopathic Medicines in patients with Parkinsons Disease.
Phase 3
- Conditions
- Health Condition 1: G20- Parkinsons disease
- Registration Number
- CTRI/2023/11/059894
- Lead Sponsor
- Dr. Aishwarya Hosmath
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Modified Hoehn and Yahr scale upto stage 4
Exclusion Criteria
1. Individuals diagnosed with other significant Neurological disorders such as multiplesclerosis,
Motor neuron disorders, and Malignancies.
2.Uncontrolled Diabetes Mellitus and Hypertension, and any severe life-threatening medical
illness.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cases will be assessed using the MDS-sponsored Revision of the Unified Parkinson’s Disease <br/ ><br>Rating Scale (MDS-UPDRS) for the Parkinson’s disease.Timepoint: 10 months
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI